30
/it/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
3512550
319423
2
Public Timelines FAQ
Public TimelinesFAQ
Public TimelinesFAQ
For educational institutions For teachers For students Open cabinet
For educational institutions For teachers For students Open cabinet
Creare
Create a timeline
Public timelines
Library
FAQ

1 gen 1997 anni - Rituximab

Descrizione:

For use in patients with treatment-resistant, low-grade or follicular B-cell non-Hodgkin lymphoma (NHL), the Food and Drug Administration (FDA) approves rituximab, a monoclonal antibody.

Aggiunto al nastro di tempo:

Cancer

ByTrinity Ozias
14 nov 2019

Data:

1 gen 1997 anni
Adesso
~ 27 years ago
About & FeedbackAccordoPrivatezzaBiblioteca
2024 © Time.Graphics
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Excellent (Trustpilot Reviews)
Based on 115+ reviews
Write your own review on Trustpilot.com